Acepod CA (30 ml) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by ABL Lifecare. This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Clavulanic Acid, Cefpodoxime Proxetil. This drug comes in the form of Suspension. The general packing available for this medicine consists of 30 ml and is priced at Rs 84.95 (arround $1.1893 US Dollar)
Generic (Salt) Combination :
(Clavulanic Acid+ Cefpodoxime Proxetil)
Pharma Company :
ABL Lifecare
Brand Label :
Acepod CA (30 ml)
Preparation Type :
Suspension
Single Dose :
5 ml
Composition (Fixed-Dose Combination) :
Cefpodoxime Proxetil-200 mg
Clavulanic Acid-125 mg
Pack Size/Qty/Vol :
30 ml
Price Unit :
Rs 14.16 INR (arround $0.19824 US Dollar)
Price Pack :
Rs 84.95 INR (arround $1.1893 US Dollar)
Drug details for Acepod CA (30 ml)
Usage: Why is this medication prescribed?
The main active ingredients or salts in Acepod CA (30 ml) are :
Cefpodoxime Proxetil-200 mg
Clavulanic Acid-125 mg
Clavulanic Acid Indication (Prescribed for or used as):
For more details on Clavulanic Acid, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Clavulanic Acid..
Cefpodoxime Proxetil Indication (Prescribed for or used as):
For more details on Cefpodoxime Proxetil, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Cefpodoxime Proxetil..
Acepod CA (30 ml) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :
There are 4 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for Acepod CA (30 ml), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Cefpodoxime Proxetil-200 mg Clavulanic Acid-125 mg). Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.